Physiogenex will be presenting a hyperinsulinemic euglycemic clamp study differentiating insulin analogues in STZ-rats, a model of experimental diabetes.
The study will be presented by Dr. François Briand, Director of Research and Business Development, during the poster session 1, on Monday October the 8th, poster #1012.

If you wish to make an appointment during the meeting with Dr. François Briand to discuss about your drug development project, please contact us.

 

mattis adipiscing dictum id ipsum elit. luctus libero. Nullam